Hui Wang, MD, PhD Providence Medical Group

Languages: English
Professional Statement
Dr. Wang is board certified in medical oncology and internal medicine. She completed a medical oncology fellowship at the Fred Hutchinson Cancer Research Center and the University of Washington in Seattle. She completed her residency training at the Medical University of Ohio, where she also received a Ph.D. in biochemistry and molcular biology. D.r Wang earned her medical degree from Shandong Medical University in China.
Education
Institution
Type
MD: Shandong Medical University School of Medicine, P.R. China PhD, Biochemistry and Molecular Biology: Medical University of Ohio, Toledo, Ohio
Medical School
Internal Medicine: Medical University of Ohio Hospital, Toledo, Ohio
Residency
National Cancer Institute, Frederick, Maryland Fred Hutchinson Cancer Research Center & University of Washington, Seattle
Fellowship
Board Certifications
  • American Board of Internal Medicine, Medical Oncology
  • American Board of Internal Medicine, Internal Medicine
Clinical Interests
  • adverse effects to anticoagulants
  • amyloidosis
  • anemia
  • antithrombin deficiency
  • b12 deficiency anemia
  • bladder cancer genomics
  • blood cancer
  • blood disorders
  • bone marrow disorders
  • brain cancer genomics
  • breast cancer genomics
  • cancer
  • cancer chemotherapy
  • cancer during pregnancy
  • cancer genomics
  • cancer pain
  • cancer risk assessment
  • cancer survivorship
  • cancer-related fatigue
  • cervical cancer genomics
  • chemoradiation
  • colon cancer genomics
  • cowden syndrome
  • crizotinib
  • egfr mutation
  • egfr translocation
  • endocrine complications of cancer therapy
  • endometrial cancer genomics
  • erlotinib
  • factor v leiden
  • gallbladder cancer genomics
  • gastrointestinal cancer genomics
  • genitourinary cancer genomics
  • gynecologic cancer genomics
  • head and neck cancer care
  • head and neck cancer genomics
  • hellp syndrome
  • hemochromatosis
  • hemolytic uremic syndrome
  • heparin induced thrombocytopenia
  • hereditary spherocytosis
  • histiocytosis
  • hypogammaglobulinemia
  • idiopathic thrombocytopenic purpura
  • iron deficiency anemia
  • langerhans cell histiocytosis
  • leukemia genomics
  • leukocytosis
  • leukopenia
  • liver cancer genomics
  • lung cancer genomics
  • lymphoma genomics
  • lymphopenia
  • maternal hematologic disorders
  • melanoma genomics
  • monoclonal gammopathy of undetermined significance
  • musculoskeletal tumor
  • myelodysplasia
  • myelodysplastic syndrome
  • myeloproliferative diseases
  • neutropenia
  • non-hodgkin lymphoma
  • oral complications of cancer
  • pancreatic cancer genomics
  • pancytopenia
  • paroxysmal nocturnal hemoglobinuria
  • petechiae
  • peutz-jeghers syndrome
  • plasma cell dyscrasia
  • polycythemia
  • prostate cancer genomics
  • pulmonary metastases
  • purpura
  • radionuclide therapy
  • rectal cancer genomics
  • renal cancer genomics
  • retroperitoneal mass
  • rh incompatibility
  • sarcoma genomics
  • secondary polycythemia
  • side effects of cancer treatment
  • skin cancer genomics
  • splenomegaly
  • stomach cancer genomics
  • submucosal tumors
  • sweat gland carcinoma
  • thalassemia
  • thrombocytopenia
  • thrombophilia
  • thrombotic thrombocytopenic purpura
  • thyroid cancer genomics
  • tracheal cancer
  • unknown primary cancer
Publications
Dr. Wang has published numerous articles and abstracts in peer-reviewed journals including Cancer, Blood, Journal of Immunology and others. She has many articles regarding leukemia research, including studies of the efficacy of different pharmacological and other therapies in treating myeloid leukemia, classification of acute leukemia and studies of lymphocytic leukemia, among others.
PATIENT RATINGS AND COMMENTS

The Patient Rating score is based on responses given during the CAHPS Patient Experience Survey.Responses are measured on a 10 - point scale, with 10 being the best score. These scores are then translated to a 5 - point scale in order to display results in a 5 - star rating.Comments are also gathered from the same survey and displayed in their entirety with the exception of any language that may be considered slander, libel or contain private health information, which will be removed prior to publishing the comments.

4.7 out of 5 (123 Ratings, 0 Comments)


 
Providence Regional Cancer System - Lacey
4525 3rd Avenue Southeast Suite 200
Lacey, WA 98503
360-943-8023
Providence Regional Cancer System - Centralia
2015 Cooks Hill Road Suite 200
Centralia, WA 98531
360-330-8916
Providence Regional Cancer System - Aberdeen
954 Anderson Drive Suite 102
Aberdeen, WA 98520
360-533-7962
Affiliated Facilities
Providence St. Peter Hospital
Providence Centralia Hospital